Literature DB >> 10497183

Properties of cloned and expressed human RNase H1.

H Wu1, W F Lima, S T Crooke.   

Abstract

We have characterized cloned His-tag human RNase H1. The activity of the enzyme exhibited a bell-shaped response to divalent cations and pH. The optimum conditions for catalysis consisted of 1 mM Mg(2+) and pH 7-8. In the presence of Mg(2+), Mn(2+) was inhibitory. Human RNase H1 shares many enzymatic properties with Escherichia coli RNase H1. The human enzyme cleaves RNA in a DNA-RNA duplex resulting in products with 5'-phosphate and 3'-hydroxy termini, can cleave overhanging single strand RNA adjacent to a DNA-RNA duplex, and is unable to cleave substrates in which either the RNA or DNA strand has 2' modifications at the cleavage site. Human RNase H1 binds selectively to "A-form"-type duplexes with approximately 10-20-fold greater affinity than that observed for E. coli RNase H1. The human enzyme displays a greater initial rate of cleavage of a heteroduplex-containing RNA-phosphorothioate DNA than an RNA-DNA duplex. Unlike the E. coli enzyme, human RNase H1 displays a strong positional preference for cleavage, i.e. it cleaves between 8 and 12 nucleotides from the 5'-RNA-3'-DNA terminus of the duplex. Within the preferred cleavage site, the enzyme displays modest sequence preference with GU being a preferred dinucleotide. The enzyme is inhibited by single-strand phosphorothioate oligonucleotides and displays no evidence of processivity. The minimum RNA-DNA duplex length that supports cleavage is 6 base pairs, and the minimum RNA-DNA "gap size" that supports cleavage is 5 base pairs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10497183     DOI: 10.1074/jbc.274.40.28270

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  Eukaryotic ribonucleases HI and HII generate characteristic hydrolytic patterns on DNA-RNA hybrids: further evidence that mitochondrial RNase H is an RNase HII.

Authors:  F Pileur; J J Toulme; C Cazenave
Journal:  Nucleic Acids Res       Date:  2000-09-15       Impact factor: 16.971

2.  Functional coupling of last-intron splicing and 3'-end processing to transcription in vitro: the poly(A) signal couples to splicing before committing to cleavage.

Authors:  Frank Rigo; Harold G Martinson
Journal:  Mol Cell Biol       Date:  2007-10-29       Impact factor: 4.272

3.  Increased efficacy of antileishmanial antisense phosphorothioate oligonucleotides in Leishmania amazonensis overexpressing ribonuclease H.

Authors:  M Mishra; J R Bennett; G Chaudhuri
Journal:  Biochem Pharmacol       Date:  2001-02-15       Impact factor: 5.858

4.  Determination of optimal sites of antisense oligonucleotide cleavage within TNFalpha mRNA.

Authors:  B H Lloyd; R V Giles; D G Spiller; J Grzybowski; D M Tidd; D R Sibson
Journal:  Nucleic Acids Res       Date:  2001-09-01       Impact factor: 16.971

5.  Synthesis, thermal stability and resistance to enzymatic hydrolysis of the oligonucleotides containing 5-(N-aminohexyl)carbamoyl-2'-O-methyluridines.

Authors:  Takanori Ito; Yoshihito Ueno; Yasuo Komatsu; Akira Matsuda
Journal:  Nucleic Acids Res       Date:  2003-05-15       Impact factor: 16.971

6.  Evidence for a dual functional role of a conserved histidine in RNA·DNA heteroduplex cleavage by human RNase H1.

Authors:  Nageswara R Alla; Allen W Nicholson
Journal:  FEBS J       Date:  2012-11-09       Impact factor: 5.542

7.  Binding and cleavage specificities of human Argonaute2.

Authors:  Walt F Lima; Hongjiang Wu; Josh G Nichols; Hong Sun; Heather M Murray; Stanley T Crooke
Journal:  J Biol Chem       Date:  2009-07-22       Impact factor: 5.157

8.  A randomised, controlled, double blind, escalating dose study of alicaforsen enema in active ulcerative colitis.

Authors:  S J H van Deventer; J A Tami; M K Wedel
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

9.  Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease.

Authors:  B R Yacyshyn; W Y Chey; J Goff; B Salzberg; R Baerg; A L Buchman; J Tami; R Yu; E Gibiansky; W R Shanahan
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

10.  Systematic analysis of the role of target site accessibility in the activity of DNA enzymes.

Authors:  Graeme Doran; Muhammad Sohail
Journal:  J RNAi Gene Silencing       Date:  2006-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.